Bernd Mühlenweg
Corporate Officer/Principal at Pharma-Lizenz-Club Deutschland
Network origin in Bernd Mühlenweg first degree
Entity | Entity type | Industry | |
---|---|---|---|
16
| Public Company | Medical Specialties | 16 |
Pharma-Lizenz-Club Deutschland
4
| Private Company | 4 | |
Pharma Licensing Club France
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bernd Mühlenweg via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Imperial Chemical Industries Ltd.
Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Chemicals: Major Diversified | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
George Washington University | College/University | Undergraduate Degree | |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The private company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
PHARMA MAR, S.A. | Pharmaceuticals: Other | Corporate Officer/Principal | |
J.C. Flowers & Co. LLC
J.C. Flowers & Co. LLC Investment ManagersFinance J.C. Flowers & Co. LLC (J.C. Flowers & Co.) is a private equity firm founded in 1998 by J. Christopher Flowers. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
INSEAD | College/University | Masters Business Admin | |
Universität zu Köln | College/University | Undergraduate Degree | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Chairman | |
EM Lyon Business School | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
Arthur Andersen & Cia
Arthur Andersen & Cia Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen & Cia is a French company. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National University of Cordoba | College/University | Doctorate Degree | |
Université Paris II Panthéon Assas | College/University | Graduate Degree | |
AIG Global Investment Group, Inc.
AIG Global Investment Group, Inc. Investment ManagersFinance Part of American International Group, Inc., AIG Global Investment Group, Inc. provides investment advisory services. The private company is based in New York, NY. The CEO of the company is Win Jay Neuger. | Investment Managers | Corporate Officer/Principal | |
Capgemini Consulting SAS
Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Chiron Therapeutics, Inc. | Corporate Officer/Principal | ||
International Drug Development Institute SA
International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Institut Supérieur de Gestion | College/University | Graduate Degree | |
Gustave Roussy Foundation
Gustave Roussy Foundation Hospital/Nursing ManagementHealth Services Gustave Roussy Foundation is a leading European cancer center that specializes in the treatment of rare cancers and complex tumors. Gustave Roussy Foundation is located in Villejuif and Chevilly-Larue, France, and has 3,200 health professionals and 4,100 professionals working on its two campuses. The institute provides expert care for all cancers at every stage of life and caters to almost 50,000 patients per year. It is a source of diagnostic and therapeutic advances and integrates research, patient care, and teaching. The institute offers personalized management that combines innovation and a human-focused approach, taking into account care and physical, psychological, and social quality of life. | Hospital/Nursing Management | Director/Board Member | |
EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Chairman | |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Investor Relations Contact | |
Fondation A.R.CA.D. | Investment Trusts/Mutual Funds | Director/Board Member | |
Alain Oncologie Consulting
Alain Oncologie Consulting Miscellaneous Commercial ServicesCommercial Services Alain Oncologie Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ad Bio Consulting
Ad Bio Consulting Miscellaneous Commercial ServicesCommercial Services Ad Bio Consulting provides business and management consulting services. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Miscellaneous Commercial Services | Chief Executive Officer | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOMX INC. | Biotechnology | Investor Relations Contact | |
Pharmaengine Europe SARL
Pharmaengine Europe SARL Pharmaceuticals: MajorHealth Technology Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The private company is based in Paris, France. The CEO of the French company is Alain Herrera. | Pharmaceuticals: Major | Chief Executive Officer | |
Impulse Consulting Ltd. | Director/Board Member | ||
Mitrychem SAS | Corporate Officer/Principal | ||
Ici Pharma | Chief Executive Officer | ||
Gustave Roussy Transfert
Gustave Roussy Transfert Miscellaneous Commercial ServicesCommercial Services Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care. | Miscellaneous Commercial Services | Director/Board Member | |
EMERCell SAS
EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed. | Pharmaceuticals: Major | Director/Board Member | |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Biotechnology | Founder | |
Zorggroep Solis BV
Zorggroep Solis BV Services to the Health IndustryHealth Services Zorggroep Solis BV provides healthcare services. The private company is based in Deventer, Netherlands. The Dutch company's team of employees, therapists, specialists, nurses, nursing assistants, and volunteers are available to assist patients. | Services to the Health Industry | Chairman | |
Baxter Oncology GmbH
Baxter Oncology GmbH Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., Baxter Oncology GmbH manufactures medicines for chemo and hormone therapy. The private company is based in Halle, Germany. The CEOs are Frank Generotzky, Bernhard Assies. The German company was founded in 1919. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
France | 25 |
United Kingdom | 8 |
United States | 8 |
Germany | 4 |
Spain | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 11 |
Commercial Services | 8 |
Finance | 4 |
Health Services | 3 |
Operational
Director/Board Member | 63 |
Corporate Officer/Principal | 61 |
Chairman | 21 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 17 |
Most connected contacts
Insiders | |
---|---|
Patrick J. Langlois | 23 |
Anne-Marie Graffin | 22 |
Alain Herrera | 17 |
Jérôme Snollaerts | 15 |
Irina Staatz-Granzer | 14 |
Christophe Douat | 13 |
Enno Spillner | 13 |
Marc Voigt | 11 |
Laurent Condomine | 11 |
Noël Kurdi | 9 |
Anne-Juliette Hermant | 9 |
Edwina Baskin-Bey | 7 |
Luc St-Onge | 6 |
Heiner Pieper | 6 |
Philippe Mauberna | 6 |
- Stock Market
- Insiders
- Bernd Mühlenweg
- Company connections